APS |
SH2B2, APS: SH2B adapter protein 2 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
119.000 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
O
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
119.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
119.000 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
JAK1 |
|
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
119.000 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
119.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
STAT3 |
|
119.000 |
Evidence |
|
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
O
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
119.000 |
Evidence |
|
HCK |
IPI00029769 |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
119.000 |
Evidence |
|
BID |
BID: BH3-interacting domain death agonist |
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT3 |
|
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
119.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|